Target intelligence / Profile preview

Putative E3 ubiquitin-protein ligase UNKL (UNKL)

Target
UNKL
Molecular classification
Enzyme, Zinc finger protein
01

Overview

Putative E3 ubiquitin-protein ligase UNKL is a zinc finger protein classified within the RING finger family, encoded by the UNKL gene (also referred to as C16orf28, ZC3H5L, ZC3HDC5L, among other aliases)[1]. It is thought to function in Rac signaling pathways and mediates protein-protein interactions by binding to the Brg/Brm-associated factor 60b, promoting its ubiquitination—a process essential for protein turnover and regulation[1]. Multiple transcript variants arise due to alternative splicing. The protein features canonical zinc finger domains, notably the RING finger and CCCH motifs, commonly known for roles in nucleic acid binding and protein regulation. While not directly linked to major disease categories in curated databases, UNKL may be implicated in cell-regulatory processes relevant to disease progression, though specifics remain unclear[1]. No direct pharmacological agents, mechanisms of action, biomarkers, or safety concerns have been reported for UNKL as of current literature[1].

Other names
C16orf28ZC3H5LZC3HDC5LFLJ23360RING finger protein unkempt-likeZinc finger CCCH domain-containing protein 5-likeUnkempt family zinc finger-likeUnkempt homolog-like
02

Biological functions

UbiquitinationProtein-protein interactionPotential signal transduction
03

Disease associations

No clear direct link to specific disease categories listed

Beyond the preview

Go deeper on Putative E3 ubiquitin-protein ligase UNKL (UNKL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Putative E3 ubiquitin-protein ligase UNKL (UNKL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call